Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 27 min ago
PreprintPublic domainbioRxiv

Metabolic profiling of licensed mesenchymal stromal cells reveals a disconnect between glycolytic fitness and immunomodulatory responsiveness

  1. 1Simon Fraser University

Abstract

Mesenchymal stromal cells (MSCs) are promising cell therapeutics, but their development as off-the-shelf products requires cryopreservation, which impairs cell function after thaw. Inflammatory licensing enhances MSC therapeutic attributes, yet protocols vary considerably and little is known about how these variables affect MSC metabolism or post-thaw recovery. We characterized mitochondrial and glycolytic flux in umbilical cord (UC) and bone marrow (BM) MSCs licensed with interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), or both. Brief exposure to either cytokine shifted MSC metabolism toward glycolysis and reduced mitochondrial respiration, whereas prolonged exposure led to heterogeneous responses. Conversely, combined IFN-γ and TNF-α increased glycolytic flux and respiratory capacity in most donors, with responses detectable after 2 hours and at concentrations below those conventionally used. Cryopreservation impaired aerobic metabolism, followed by donor-dependent recovery. Preconditioning with combined IFN-γ and TNF-α partially improved post-thaw metabolism, particularly in BM MSCs, and enhanced early responsiveness to inflammatory challenge, particularly in UC MSCs, as detected by IDO and candidate biomarkers CTSS and C1S . However, donors with improved post-thaw metabolism did not consistently show increased biomarker responses. These findings demonstrate that metabolic fitness and inducible biomarkers capture complementary aspects of post-thaw MSC quality and may inform preconditioning strategies for cryopreserved MSC products.

Related

  1. TGFB1-Engineered Induced Mesenchymal Stromal Cells Exhibit High Immunomodulatory Potency and Durably Reprogram Synovial Macrophages in Osteoarthritis
    K. Fan, M. Rasti, R. Khan +9
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  2. Distinct metabolic states of yeast and pseudohyphae differentially prime innate immune responsiveness
    H. Kato, M. NandyMazumdar, Z. Rahmani +6
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
  3. Metabolic Responsiveness of Olive (Olea europaea L.) Cultivars Following Foliar Silicon Application: A Comparative LC–MS/MS Study
    Paula Žurga, Igor Pasković, Nikola Major +4
    Plants (Basel, Switzerland)Peer-reviewedCC BYFull textPlant biologyEurope PMC
  4. The metabolic crossfire hypothesis: glycolytic crosstalk between immune and epithelial cells in ulcerative colitis pathogenesis
    Liyao Wu, Jinyin Xiao, Chunhua Liu +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyCrossref
  5. Metabolic atlas of early human cortex reveals glycolytic remodeling and pentose phosphate pathway control of cell fate transitions
    Jessenya Mil, Jose A. Soto, Abigail S. Krall +24
    CellPeer-reviewedCC BY-NCFull text11 citedNeuroscienceOpenAlex
BibTeX
@misc{bilal2026metabolic,
  title = {{Metabolic profiling of licensed mesenchymal stromal cells reveals a disconnect between glycolytic fitness and immunomodulatory responsiveness}},
  author = {H. Bilal and B. T. DeGroot and L. Braid},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.27.754820},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.27.754820v1},
  note = {Public domain},
}
RIS
TY  - UNPB
TI  - Metabolic profiling of licensed mesenchymal stromal cells reveals a disconnect between glycolytic fitness and immunomodulatory responsiveness
AU  - H. Bilal
AU  - B. T. DeGroot
AU  - L. Braid
PY  - 2026
DA  - 2026/09/27
PB  - bioRxiv
DO  - 10.64898/2026.09.27.754820
UR  - https://www.biorxiv.org/content/10.64898/2026.09.27.754820v1
AB  - Mesenchymal stromal cells (MSCs) are promising cell therapeutics, but their development as off-the-shelf products requires cryopreservation, which impairs cell function after thaw. Inflammatory licensing enhances MSC therapeutic attributes, yet protocols vary considerably and little is known about how these variables affect MSC metabolism or post-thaw recovery. We characterized mitochondrial and glycolytic flux in umbilical cord (UC) and bone marrow (BM) MSCs licensed with interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), or both. Brief exposure to either cytokine shifted MSC metabolism toward glycolysis and reduced mitochondrial respiration, whereas prolonged exposure led to heterogeneous responses. Conversely, combined IFN-γ and TNF-α increased glycolytic flux and respiratory capacity in most donors, with responses detectable after 2 hours and at concentrations below those conventionally used. Cryopreservation impaired aerobic metabolism, followed by donor-dependent recovery. Preconditioning with combined IFN-γ and TNF-α partially improved post-thaw metabolism, particularly in BM MSCs, and enhanced early responsiveness to inflammatory challenge, particularly in UC MSCs, as detected by IDO and candidate biomarkers CTSS and C1S . However, donors with improved post-thaw metabolism did not consistently show increased biomarker responses. These findings demonstrate that metabolic fitness and inducible biomarkers capture complementary aspects of post-thaw MSC quality and may inform preconditioning strategies for cryopreserved MSC products.
ER  -